NDC 0409-5093

TAZICEF

Ceftazidime

TAZICEF is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Ceftazidime.

• Product ID: 0409-5093_0b84920a-5767-4665-bdfc-50bbfcea6d97
• NDC: 0409-5093
• Product Type: Human Prescription Drug
• Proprietary Name: TAZICEF
• Generic Name: Ceftazidime
• Dosage Form: Injection, Powder, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2006-04-05
• Marketing Category: ANDA / ANDA
• Application Number: ANDA064032
• Labeler Name: Hospira, Inc.
• Substance Name: CEFTAZIDIME
• Active Ingredient Strength: 2 g/1
• Pharm Classes: Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0409-5093-11

10 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5093-11) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-5093-14)

• Marketing Start Date: 2006-04-05
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0409-5093-11 [00409509311]

TAZICEF INJECTION, POWDER, FOR SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA064032
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2006-04-05

NDC 0409-5093-51 [00409509351]

TAZICEF INJECTION, POWDER, FOR SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA064032
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2012-03-06
• Marketing End Date: 2014-10-30

NDC 0409-5093-14 [00409509314]

TAZICEF INJECTION, POWDER, FOR SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA064032
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2018-11-13

Drug Details

Active Ingredients

Ingredient	Strength
CEFTAZIDIME	2 g/1

OpenFDA Data

• SPL SET ID: 9b73979c-c95a-4433-0a9d-f9cea3cb557f
• Manufacturer:
  • Hospira, Inc.
• UNII:
  • 9M416Z9QNR
• RxNorm Concept Unique ID - RxCUI:
  • 1659292
  • 1659294
  • 1659283
  • 1659287

Pharmacological Class

• Cephalosporin Antibacterial [EPC]
• Cephalosporins [CS]

NDC Crossover Matching brand name "TAZICEF" or generic name "Ceftazidime"

NDC	Brand Name	Generic Name
0409-5082	TAZICEF	CEFTAZIDIME
0409-5084	TAZICEF	CEFTAZIDIME
0409-5086	TAZICEF	CEFTAZIDIME
0409-5092	TAZICEF	CEFTAZIDIME
0409-5093	TAZICEF	CEFTAZIDIME
0781-3177	Ceftazidime	Ceftazidime
0781-3178	Ceftazidime	Ceftazidime
0781-3179	Ceftazidime	Ceftazidime
25021-127	Ceftazidime	ceftazidime
0264-3143	Ceftazidime and Dextrose	CEFTAZIDIME
0264-3145	Ceftazidime and Dextrose	CEFTAZIDIME